All
DTC Advertising: Friend or Foe?
November 15th 2002Direct-to-consumer advertising in U.S. healthcare is at both a zenith and crossroads where capitalism meets the ethical practice of medicine. DTC spending has never been higher, rising steadily since the U.S. Food and Drug Administration approved the tactic in 1997.
Pain control crucial when using RF
October 1st 2002Atlanta - A radiofrequency device for aesthetic and therapeutic applications has the potential to revolutionize cosmetic surgery, but pain control measures must be a high priority for the device to be used at an effective fluence, said Richard E. Fitzpatrick, M.D., of Dermatology Associates/Cosmetic Laser Associates of San Diego County.
Fat rebalancing more natural alternative to lifts
October 1st 2002New Orleans - Restoring the primary structural arcs of the face through facial fat rebuilding is a more effective alternative to conventional cosmetic surgery of the aging face, Lisa M. Donofrio, M.D., said at the annual meeting of the American Academy of Dermatology.
Bleeding complications formidable, manageable
October 1st 2002Paris - While prevention is the best strategy for managing bleeding complications of cutaneous reconstruction, when that fails, a favorable outcome is still likely given proper care, David Zloty, M.D., said at the World Congress of Dermatology.
Revision strategies aim to improve scar cosmesis
October 1st 2002Paris - Tincture of time can be better than any early intervention for optimizing scar appearance, but various surgical and nonsurgical techniques, when used at appropriate intervals, can be effective for hastening that process or addressing lesions that remain unacceptable after following a wait-and-see approach, Neil Swanson, M.D., said at the World Congress of Dermatology.
Refined flap concepts enhance nasal appearance
October 1st 2002Paris - Refinements and advances in flap techniques used to repair nasal defects after skin cancer surgery have been valuable for improving flap survival and cosmetic outcomes, even of large defects, Marc D. Brown, M.D., said at the World Congress of Dermatology.
New laser modality improves transdermal delivery of 5-FU
October 1st 2002Los Angeles - Laser pretreatment dramatically increases the transdermal delivery of the chemotherapeutic agent 5-FU, according to Dr. Kuo-Hsien Wang, M.D. who presented at the Society for Investigative Dermatology annual meeting. "This method has potential for the treatment of cutaneous malignant diseases and precancerous lesions, such as actinic keratosis, Bowen's disease, and superficial basal cell carcinoma," he said.
Creatine may prevent UV damage, repair skin tissue
October 1st 2002Orlando - Cellular energy supplied through substrates of the creatine kinase system accelerates skin repair and healing, reduces sunburn, and protects skin from UV damage. The processes, in turn, can improve skin quality, moisture retention, and suppleness, according to Nadim Shaath, Ph.D., president of Alpha Research and Development Ltd., White Plains, N.Y.
Angiogenesis research provides foundation for drug development
October 1st 2002Paris - Increased understanding of the basic molecular mechanisms involved in angiogenesis has suggested new targets for treating a number of dermatological and other diseases, and many compounds affecting angiogenesis are in clinical trials. However, questions remain to be answered about potential strategies for optimizing the efficacy of pro- and anti-angiogenic interventions and the safety of these novel treatments, Peter Carmeliet, Ph.D., said at the World Congress of Dermatology.
Tazarotene indications may soon expand
October 1st 2002Los Angeles - Already approved for the treatment of acne, tazarotene (Tazorac) is being investigated for the treatment of facial photodamage and clogged pores. The FDA is expected to grant regulatory approval for tazarotene to treat photodamaged facial skin within a few months.
Some hope remains this year for Medicare bill
October 1st 2002There is still hope for a Medicare "giveback" bill before Congress adjourns for good this year, and the possibility of a broader Medicare drug benefit than the discount card just announced by the Bush administration could be the best last chance to get this done.
Long-term tretinoin use improves cellular atypia
October 1st 2002Los Angeles - Dermatologists concerned that long-term topical tretinoin use might worsen epidermal cellular atypia can rest assured it does not, according to a study presented at the annual meeting of the Society for Investigational Dermatology. In fact, the treatment used commonly to rid patients of the fine lines and mottled discoloration of sun damage improves epidermal cellular atypia.
Stem cells may aid in postischemic revascularization
September 15th 2002Los Angeles - The restoration of the blood flow in ischemic limbs in mice is accelerated when epidermal stem cells are injected into the site, Martine Dunnwald, PharmD, Ph.D., told colleagues at the annual meeting of the Society for Investigative Dermatology.